What are the potential adverse effects of mineralocorticoid receptor antagonists (MRAs) in people with heart failure with reduced ejection fraction (HFREF)?
The potential adverse effects of MRAs in people with HFREF include electrolyte disturbances (particularly hyperkaleaemia) and worsening renal dysfunction, which can result in increased morbidity and hospitalisations.